Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04764448
Status:
TERMINATED
Last Update Posted:
2024-07-12
First Post:
2021-01-27
Brief Title:
A Study of Belcesiran in Patients With AATLD
Sponsor:
Dicerna Pharmaceuticals Inc a Novo Nordisk company
Organization:
Novo Nordisk AS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-29
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-27
First Submit QC Date:
February 17 2021
Study First Post Date:
2021-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-11
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL